Eyerising Myopia Management Device
The Eyerising myopia management device uses proprietary technology for administering Repeated Low-Level Red-Light (RLRL) therapy that enhances blood circulation in the ocular fundus, addressing sclera hypoxia and managing the axial elongation associated with myopia. It is backed by 2-year clinical trial results showing myopia control efficacy, and complies with Australian Standard IEC 60825-1:2014 for laser products safety.
Visit the Eyerising Myopia Management Device website.
Eyerising International resources
Eyerising International and Myopia Profile Interview Series: Highlights
Eyerising International recently undertook a series of video interviews where global experts spoke to Dr Kate Gifford of Myopia Profile about their clinical experiences, observations and work with the Eyerising Myopia Management Device.
To watch the interviews in full, please visit
Enormous thanks to our visionary sponsors
Myopia Profile’s growth into a world leading platform has been made possible through the support of our visionary sponsors, who share our mission to improve children’s vision care worldwide. Click on their logos to learn about how these companies are innovating and developing resources with us to support you in managing your patients with myopia.